Skip to content

A monocentric, retrospective and prospective, non-randomised, clinical survey to evaluate Mpact cup performance 5 years following Total hip arthroplasty

A monocentric, retrospective and prospective, non-randomised, clinical survey to evaluate Mpact cup performance 5 years following Total hip arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623000788673
Enrollment
52
Registered
2023-07-19
Start date
2017-01-16
Completion date
2017-12-04
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Mpact cup is a modular hemispherical press-fit acetabular shell with an external Titanium porous coating called Ti-Growth (Medacta commercial name: MectaGrip). The primary objective of this study is to evaluate Mpact clinical and radiological performance through modified HHS and standard X-rays. The secondary objectives are to evaluate five-year survival rate of the Mpact cup and to quantify and document any associated complications

Interventions

Total hip arthroplasty (THA) is one of the most commonly performed and successful orthopaedic operations in improving a patient’s quality of life. Orthopaedic surgeons are continually striving to improve all aspects of care relating to this procedure whether this is improvements in implant technology, instrument improvement, or the technique involved in performing the procedure. During the last decade, a new titanium porous coating was introduced to improve the osteointegration for the uncement

Total hip arthroplasty (THA) is one of the most commonly performed and successful orthopaedic operations in improving a patient’s quality of life. Orthopaedic surgeons are continually striving to improve all aspects of care relating to this procedure whether this is improvements in implant technology, instrument improvement, or the technique involved in performing the procedure. During the last decade, a new titanium porous coating was introduced to improve the osteointegration for the uncemented acetabular component. A high surface friction and scratch-fit allows for secure initial fixation, whereas the high porosity ensures bony ingrowth thus providing secondary long term stability. With higher porosity in respect with standard coatings, for any given percentage filling, a greater volume of bone is present within the porous surface, thus giving a proportionate increase in interface strength. Mpact cup is a modular hemispherical press-fit acetabular shell with an external Titanium porous coating called Ti-Growth (Medacta commercial name: MectaGrip). The primary objective of this study is to evaluate Mpact clinical and radiological performance through the modified Harris Hip Score (MHSS) and standard x-rays. 50 patients who had underwent a THA with a Mpact cup will be recruited during the 5-year follow-up visit to be observed up to 5-years post-surgery. Retrospectively collected data includes surgical details such as device implanted and complications that occurred, and postoperative clinical and radiological assessments. MHSS at the 5year follow-up will be collected prospectively which is anticipated to take 10minutes to complete. Radiographic assessments and adverse event reports, if required, will also be completed prospectively.

Sponsors

Medacta Australia Pty Ltd
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

• Patient who underwent THA from March 2011 till November 2011. • Patient who received a Mpact cup. • Patient who agrees to comply with the study protocol. • Patient who gave their consent to the treatment of his/her clinical data

Exclusion criteria

• Minor patient • Pregnant or breast feeding woman • Patient who is not able to provide consent for participation in the study. • Patient refusing data collection

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026